Compare · head to head
LENSAR vs Pulse Biosciences
LENSAR ranks higher overall — 360 rank 88 vs 45.
LENSAR leads on Quality (48 vs 30), Safety (70 vs 62) and Sentiment (62 vs 47). Pulse Biosciences leads on Growth (56 vs 51).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| Size | Small | Small |
| ISIN | US52634L1089 | US74587B1017 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 88 | 45 |
| Value | 60 | NR |
| Quality | 48 | 30 |
| Growth | 51 | 56 |
| Safety | 70 | 62 |
| Sentiment | 62 | 47 |
| Quality details | ||
| Profitability | 59 | 12 |
| Cash Truth | 37 | 47 |
LENSAR vs NovLENSAR vs Caris Life SciencesLENSAR vs Xeris PharmaceuticalsLENSAR vs RoadzenAdd a third stock →
Full analyses: LENSAR · Pulse Biosciences
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100